The biotech industry celebrated a Supreme Court ruling supporting FDA’s regulation of the abortion pill, preventing potential destabilization. Industry leaders, like John Maraganore and Daphne Zohar, praised the decision for upholding science and women’s rights. FDA Commissioner Robert Califf expressed joy during a meeting. The FDA also discussed improving expert advisory committees, addressing concerns about patient representation and conflicts of interest. Other topics in biotech include Pfizer’s Duchenne therapy setback, Lilly’s Alzheimer’s drug approval, and J.P. Morgan’s venture into early-stage biotech investing. Additionally, a startup aims to manage immune system anger. The content also covers telehealth fraud charges and critiques on the US response to a bird flu outbreak.
Source link
J.P. Morgan, mifepristone, Cabaletta Bio news
